Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCitigroup Inc Regulatory News (13PH)

  • There is currently no data for 13PH

Form 8.3 - offeree

27 May 2021 15:34

RNS Number : 0901A
Citigroup Inc
27 May 2021
Β 

Ap19

Β 

Β 

FORM 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Citigroup Inc.

Company dealt in

Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

Β 26 May 2021

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Β 

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

3,552,390 2.75%

1,267,881 0.98%

(2) Derivatives (other than options)

28,937 0.02%

36,368 0.03%

(3) Options and agreements to purchase/sell

Β 

Total

3,581,327 2.78%

1,304,249 1.01%

Β Β Β Β Β Β Β 

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

Β 

Β 

Β 

(2) Derivatives (other than options)

Β 

Β 

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

Β 

Β 

Β Β Β Β Β Β Β 

Β 

Ap20

Β 

Β 

1. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (USD)

Purchase

47,687

Β Highest 261.83 Lowest 259.83

Sale

344

Highest 261.15 Lowest 260.06

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

Β 

Β 

Β 

Β 

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Β 

Β 

Β 

Β 

Ap21

Β 

2. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β this shouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β NO

Β 

Date of disclosure

27 May 2021

Contact name

Damian Flanagan

Telephone number

+ 44 (0) 2890 409 676

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUBOSRASUVUAR
Date   Source Headline
24th Jun 20213:30 pmRNSForm 8.3 - offeree
23rd Jun 20214:44 pmRNSForm 8.3 - offeree
22nd Jun 20214:22 pmRNSForm 8.3 - offeree
21st Jun 20213:25 pmRNSForm 8.3 - offeree
18th Jun 20212:42 pmRNSForm 8.3 - offeree
17th Jun 20212:59 pmRNSForm 8.3 - offeree
16th Jun 20212:35 pmRNSForm 8.3 - offeree
15th Jun 20212:48 pmRNSForm 8.3 - offeree
14th Jun 20213:38 pmRNSForm 8.3 - offeree
11th Jun 20213:58 pmRNSForm 8.3 - offeree
10th Jun 20213:43 pmRNSForm 8.3 - offeree
9th Jun 20213:48 pmRNSForm 8.3 - offeree
8th Jun 20214:18 pmRNSForm 8.3 - offeree
7th Jun 20213:27 pmRNSForm 8.3 - offeree
4th Jun 20211:58 pmRNSForm 8.3 - offeree
3rd Jun 20212:36 pmRNSForm 8.3 - offeree
2nd Jun 20212:59 pmRNSForm 8.3 - offeree
1st Jun 20219:34 amRNSForm 8.3 - offeree
28th May 20214:01 pmRNSForm 8.3 - offeree
27th May 20213:34 pmRNSForm 8.3 - offeree
26th May 20214:11 pmRNSForm 8.3 - offeree
25th May 20213:46 pmRNSForm 8.3 - offeree
24th May 20215:01 pmRNSForm 8.3 - offeree
21st May 20213:18 pmRNSForm 8.3 - offeree
20th May 20213:10 pmRNSForm 8.3 - offeree
19th May 20212:50 pmRNSForm 8.3 - offeree
18th May 20213:01 pmRNSForm 8.3 - offeree
17th May 20212:41 pmRNSForm 8.3 - offeree
14th May 20213:58 pmRNSForm 8.3 - offeree
13th May 20213:23 pmRNSForm 8.3 - offeree
12th May 20213:50 pmRNSForm 8.3 - offeree
11th May 20213:59 pmRNSForm 8.3 - offeree
10th May 20213:49 pmRNSForm 8.3 - offeree
7th May 20212:35 pmRNSForm 8.3 - offeree
6th May 20213:54 pmRNSForm 8.3 - offeree
5th May 20214:29 pmRNSForm 8.3 - offeree
4th May 20213:06 pmRNSForm 8.3 - Willis Towers Watson PLC
4th May 20213:04 pmRNSForm 8.3 - Willis Towers Watson plc
4th May 20212:56 pmRNSForm 8.3 - offeree
4th May 202111:22 amRNSForm 8 (DD) - offeree
30th Apr 20212:29 pmRNSForm 8 (DD) - offeree
29th Apr 20213:13 pmRNSForm 8.3 - offeree
28th Apr 20213:05 pmRNSForm 8.3 - offeree
27th Apr 20213:10 pmRNSForm 8.3 - offeree
27th Apr 20217:41 amRNSForm 8.3 - offeree-Amendment
26th Apr 20213:04 pmRNSForm 8.3 - [offeree]
23rd Apr 20213:17 pmRNSForm 8.3 - offeree
22nd Apr 20213:22 pmRNSForm 8.3 - offeree
22nd Apr 202112:01 pmRNSForm 8.3 - offeree - Amendment
22nd Apr 202111:49 amRNSForm 8.3 - offeree - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.